News

Ardena Expands Bioanalytical Services in the Netherlands

October 31, 2024

A new laboratory will be built in Oss, while additional capacity and capabilities will be added to the Bioanalytical Center of Excellence in Assen.

Strategic Insights for 2025

October 31, 2024

Alec McChesney (BD Director, SCORR Marketing) discusses goal setting and alignment between life sciences marketing and business development teams.

Lilly and ViaNautis Bio Partner on Development of Novel Therapeutics Delivering Genetic Cargo

October 31, 2024

The partnership will use ViaNautis’ proprietary polyNaut technology platform to develop genetic medicines that can precisely target tissue types.

Abzena Expands Microbiology Laboratory Space

October 30, 2024

The company will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site.

WHO Activates Global Health Emergency Corp in Response to Mpox

October 29, 2024

WHO and its partners are providing support to countries dealing with mpox outbreaks.

AAPS PharmSci 360 2024: Big Data and Variation in Excipient Production

October 29, 2024

Pauline Janssen of DFE Pharma gave a presentation on the utility of analyzing big data sets to better understand and diagnose variability in the production process.

Novartis and Monte Rosa Therapeutics Form $2.1 Billion Global License Agreement for MGD-based Therapeutics

October 29, 2024

The collaboration aims to advance clinical development of a Phase I drug candidate, MRT-6160, and to explore other therapeutic opportunities across multiple indications.

BioDuro-Sundia Opens New Kilogram Laboratory at Shanghai Site

October 25, 2024

The laboratory is on the same site as BioDuro-Sundia’s new Compound Management Center, which was launched earlier in October 2024.

Regulatory Collaboration on Mpox Treatments Summarized in Report

October 25, 2024

The report highlights international regulators’ plans for the development and availability of vaccines to prevent and drugs to treat mpox.

CPHI Milan 2024: Highlighting the Benefits of Integrated Services

October 25, 2024

Pharmaceutical Technology Europe chats with Kevin Li, MBA, from BioDuro-Sundia about integrated services and the benefits these services can provide to pharma companies.